Mr. William Lerner, Esq. nominated to the Board of Directors of Sanomedics International Holdings, Inc.

  Mr. William Lerner, Esq. nominated to the Board of Directors of Sanomedics
                         International Holdings, Inc.

PR Newswire

MIAMI, March 8, 2013

MIAMI, March 8, 2013 /PRNewswire/ --Sanomedics International Holdings, Inc.
(OTCQB: SIMH), a medical technology holding Company that focuses on game
changing products, services and ideas, announces that William Lerner, Esq. has
been nominated to serve as a director of the Company.

Mr. Lerner, a graduate of Cornell University and of the New York University
School of Law, is a member of the bars of New York and Pennsylvania, with a
Peer Rating for more than 25 years of AV (Martindale Hubbell). His career
includes service with the U.S. Securities & Exchange Commission, The American
Stock Exchange and as General Counsel to a major New York Stock Exchange
brokerage/investment banking/financial services firm. Most recently Mr. Lerner
has been and is engaged in the private practice of corporate and securities
law in New York and in Pennsylvania,and in Toronto, Canada as a Consultant
inprovidingstrategic and legal consultingas well as corporate governance
and crisis management services to both public and private companies both in
the United States and in Canada.

Mr. Lerner is also a member of the Board of Trustees (and Chairman of the
Compliance Committee) of the Daily Income Fund, a money market mutual fund
whose portfolio is managed by Reich & Tang Asset Management, LLC (NYC). The
Manager is an affiliate of Natixis Global Asset Management headquartered in
Paris, France and Boston, Massachusetts.

Mr. Lerner is a director of National Holdings Corporation, a holding company
for National Securities Corporation, vFinance Investments, Inc., National
Asset Management, Inc. and National Insurance Corporation. National Securities
and vFinance are broker-dealers registered with the Securities and Exchange
Commission, and members of FINRA and SIPC. National Asset Management is an SEC
registered investment adviser, and National Insurance provides a full array of
fixed insurance products. (See:

Mr. Lerner is an adviser to Fiduciary Compliance Associates LLC (formed by
Charles Lerner Esq., former Special Counsel to the Division of Enforcement at
the SEC in Washington, DC and Director of Enforcement at the Pension and
Welfare Benefits Administration at the US Department of Labor). Fiduciary
Compliance ( provides full service compliance support to
investment advisers, private investment funds, and financial firms in the US
and Europe.

Sanomedics International Holdings Keith Houlihan, Co-founder and President
stated, "We are very excited to have someone of Mr. Lerner's caliber and
experience on our Board to help guide us as we implement our strategy and take
advantage of the market opportunities ahead."

Additionally the Company announces acceptance of the resignation of its CEO,
Mr. Dom Gatto effective March 8, 2013. Mr. Gatto gladly offered to assist the
Company during the transition and search for a replacement. Pending a
replacement the company's present management team will share in the CEO's

About Sanomedics
Sanomedics International Holdings, Inc. (SIMH) is a medical technology holding
company that focuses on game changing products, services and ideas – a place
where physicians, entrepreneurs, and medical companies can work together to
drive innovative technologies through concept, development, and ultimately
commercialization. We plan to grow our existing business organically and
through strategic acquisitions specifically relating to sleep disorder
diagnosis treatments. Sanomedics seeks to acquire sleep therapy operating
businesses and our strategy is to integrate a portfolio of world-class
products and service providers in the growing Sleep Apnea market. Our goal is
to provide Sleep Apnea patients with a reliable and integrated "end-to-end"
service platform.

Forward Looking Statements
This press release may contain statements which constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995, including statements regarding the intent belief or current
expectations of the Company, its directors, or its officers with respect to
the future operating performance of the Company Investors are cautioned that
any such forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, and that actual results may differ
materially from those in the forward-looking statements as a result of various
factors. The Company's periodic filings with the Securities and Exchange
Commission should be viewed for a complete understanding of risk and

Contact: Keith Houlihan, 305-433-7814,

SOURCE Sanomedics International Holdings, Inc.
Press spacebar to pause and continue. Press esc to stop.